As we did not see evidence of increased tumor-accumulation of transferred OVA-specific OT-I cells following cytokine treatments, we decided to analyze the phenotype and activation status of tumor-infiltrating CD8+ T-cells. This evidence concerns the gene CD8A and neoplasm.